Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease

ACS Chemical Neuroscience

Volumn 5, Issue 2, 2014, Pages 83-92

  Baptista, Filipa I ^a   Henriques, Ana G ^a   Silva, Artur M S ^a   Wiltfang, Jens ^b   Da Cruz E Silva, Odete A B ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Alzheimer's disease; amyloid beta; amyloid precursor protein; BACE 1; Flavonoids; signaling; tau

Indexed keywords

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; FLAVONOIDS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-SERINE-THREONINE KINASES; TAU PROTEINS;

EID: 84894469764     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400213r     Document Type: Review

References (127)

1. Holtzman, D. M., Morris, J. C., and Goate, A. M. (2011) Alzheimer's disease: the challenge of the second century Sci. Transl. Med. 3, 77sr71
2. Gendron, T. F. and Petrucelli, L. (2009) The role of tau in neurodegeneration Mol. Neurodegener. 4, 13
3. Selkoe, D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease Trends Cell Biol. 8, 447-453
4. Francis, P. T. (2005) The interplay of neurotransmitters in Alzheimer's disease CNS Spectrums 10, 6-9
5. Reinikainen, K. J., Soininen, H., and Riekkinen, P. J. (1990) Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy J. Neurosci. Res. 27, 576-586
6. Scheff, S. W., Price, D. A., Schmitt, F. A., and Mufson, E. J. (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment Neurobiol. Aging 27, 1372-1384
7. Desikan, R. S., Sabuncu, M. R., Schmansky, N. J., Reuter, M., Cabral, H. J., Hess, C. P., Weiner, M. W., Biffi, A., Anderson, C. D., Rosand, J., Salat, D. H., Kemper, T. L., Dale, A. M., Sperling, R. A., and Fischl, B. (2010) Selective disruption of the cerebral neocortex in Alzheimer's disease PloS One 5, e12853
8. Wasco, W., Gurubhagavatula, S., Paradis, M. D., Romano, D. M., Sisodia, S. S., Hyman, B. T., Neve, R. L., and Tanzi, R. E. (1993) Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor Nat. Genet. 5, 95-100
9. Coulson, E. J., Paliga, K., Beyreuther, K., and Masters, C. L. (2000) What the evolution of the amyloid protein precursor supergene family tells us about its function Neurochem. Int. 36, 175-184
10. Bayer, T. A., Cappai, R., Masters, C. L., Beyreuther, K., and Multhaup, G. (1999) It all sticks together - the APP-related family of proteins and Alzheimer's disease Mol. Psychiatry 4, 524-528
11. Hartmann, T., Bieger, S. C., Bruhl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., and Beyreuther, K. (1997) Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides Nat. Med. 3, 1016-1020
12. Greenfield, J. P., Tsai, J., Gouras, G. K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S. S., Greengard, P., and Xu, H. (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides Proc. Natl. Acad. Sci. U.S.A. 96, 742-747
13. Sisodia, S. S. (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease Proc. Natl. Acad. Sci. U.S.A. 89, 6075-6079
14. Nordstedt, C., Caporaso, G. L., Thyberg, J., Gandy, S. E., and Greengard, P. (1993) Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells J. Biol. Chem. 268, 608-612
15. Caporaso, G. L., Takei, K., Gandy, S. E., Matteoli, M., Mundigl, O., Greengard, P., and De Camilli, P. (1994) Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta/A4 amyloid precursor protein J. Neurosci. 14, 3122-3138
16. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286, 735-741
17. Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashier, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., Carter, D. B., Tomasselli, A. G., Parodi, L. A., Heinrikson, R. L., and Gurney, M. E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity Nature 402, 533-537
18. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., and Wong, P. C. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons Nat. Neurosci. 4, 233-234
19. Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., Martin, L., Louis, J. C., Yan, Q., Richards, W. G., Citron, M., and Vassar, R. (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation Nat. Neurosci. 4, 231-232
20. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S., Freedman, S. B., Frigon, N. L., Games, D., Hu, K., Johnson-Wood, K., Kappenman, K. E., Kawabe, T. T., Kola, I., Kuehn, R., Lee, M., Liu, W., Motter, R., Nichols, N. F., Power, M., Robertson, D. W., Schenk, D., Schoor, M., Shopp, G. M., Shuck, M. E., Sinha, S., Svensson, K. A., Tatsuno, G., Tintrup, H., Wijsman, J., Wright, S., and McConlogue, L. (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics Hum. Mol. Genet. 10, 1317-1324
21. Kao, S. C., Krichevsky, A. M., Kosik, K. S., and Tsai, L. H. (2004) BACE1 suppression by RNA interference in primary cortical neurons J. Biol. Chem. 279, 1942-1949
22. Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., and Disterhoft, J. F. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease Neuron 41, 27-33
23. Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. L., Beach, T., Sue, L., Wong, P., Price, D., Li, R., and Shen, Y. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nat. Med. 9, 3-4
24. Johnston, J. A., Liu, W. W., Todd, S. A., Coulson, D. T., Murphy, S., Irvine, G. B., and Passmore, A. P. (2005) Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease Biochem. Soc. Trans. 33, 1096-1100
25. Hussain, I., Hawkins, J., Harrison, D., Hille, C., Wayne, G., Cutler, L., Buck, T., Walter, D., Demont, E., Howes, C., Naylor, A., Jeffrey, P., Gonzalez, M. I., Dingwall, C., Michel, A., Redshaw, S., and Davis, J. B. (2007) Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo J. Neurochem. 100, 802-809
26. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., and Haass, C. (2006) Control of peripheral nerve myelination by the beta-secretase BACE1 Science 314, 664-666
27. Fox, N., Harvey, R. J., and Rossor, M. N. (1996) Protein folding, nucleation phenomena and delayed neurodegeneration in Alzheimer's disease Rev. Neurosci. 7, 21-28
28. Hyman, B. T., Augustinack, J. C., and Ingelsson, M. (2005) Transcriptional and conformational changes of the tau molecule in Alzheimer's disease Biochim. Biophys. Acta 1739, 150-157
29. Garcia-Sierra, F., Ghoshal, N., Quinn, B., Berry, R. W., and Binder, L. I. (2003) Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease J. Alzheimer's Dis. 5, 65-77
30. Alonso, A. D., Grundke-Iqbal, I., Barra, H. S., and Iqbal, K. (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau Proc. Natl. Acad. Sci. U.S.A. 94, 298-303
31. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., and Mandelkow, E. (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease J. Cell Biol. 143, 777-794
32. Rodriguez-Martin, T., Cuchillo-Ibanez, I., Noble, W., Nyenya, F., Anderton, B. H., and Hanger, D. P. (2013) Tau phosphorylation affects its axonal transport and degradation Neurobiol. Aging 34, 2146-2157
33. da Cruz e Silva, O. A., Fardilha, M., Henriques, A. G., Rebelo, S., Vieira, S., and da Cruz e Silva, E. F. (2004) Signal transduction therapeutics: relevance for Alzheimer's disease J. Mol. Neurosci. 23, 123-142
34. Nakaya, T. and Suzuki, T. (2006) Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD Genes Cells 11, 633-645
35. Lee, M. S., Kao, S. C., Lemere, C. A., Xia, W., Tseng, H. C., Zhou, Y., Neve, R., Ahlijanian, M. K., and Tsai, L. H. (2003) APP processing is regulated by cytoplasmic phosphorylation J. Cell Biol. 163, 83-95
36. da Cruz e Silva, E. F. and da Cruz e Silva, O. A. (2003) Protein phosphorylation and APP metabolism Neurochem. Res. 28, 1553-1561
37. Rebelo, S., Vieira, S. I., Esselmann, H., Wiltfang, J., da Cruz e Silva, E. F., and da Cruz e Silva, O. A. (2007) Tyrosine 687 phosphorylated Alzheimer's amyloid precursor protein is retained intracellularly and exhibits a decreased turnover rate Neurodegener. Dis. 4, 78-87
38. Iijima, K., Ando, K., Takeda, S., Satoh, Y., Seki, T., Itohara, S., Greengard, P., Kirino, Y., Nairn, A. C., and Suzuki, T. (2000) Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5 J. Neurochem. 75, 1085-1091
39. Aplin, A. E., Gibb, G. M., Jacobsen, J. S., Gallo, J. M., and Anderton, B. H. (1996) In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta J. Neurochem. 67, 699-707
40. Liu, F., Su, Y., Li, B., Zhou, Y., Ryder, J., Gonzalez-DeWhitt, P., May, P. C., and Ni, B. (2003) Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5 FEBS Lett. 547, 193-196
41. Standen, C. L., Brownlees, J., Grierson, A. J., Kesavapany, S., Lau, K. F., McLoughlin, D. M., and Miller, C. C. (2001) Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3) J. Neurochem. 76, 316-320
42. Taru, H., Iijima, K., Hase, M., Kirino, Y., Yagi, Y., and Suzuki, T. (2002) Interaction of Alzheimer's beta -amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade J. Biol. Chem. 277, 20070-20078
43. Sontag, E., Nunbhakdi-Craig, V., Sontag, J. M., Diaz-Arrastia, R., Ogris, E., Dayal, S., Lentz, S. R., Arning, E., and Bottiglieri, T. (2007) Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation J. Neurosci. 27, 2751-2759
44. Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M. L., Yardin, C., and Terro, F. (2013) Tau protein kinases: involvement in Alzheimer's disease Ageing Res. reviews 12, 289-309
45. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res. Rev. 33, 95-130
46. Gong, C. X. and Iqbal, K. (2008) Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease Curr. Med. Chem. 15, 2321-2328
47. Avila, J., Lucas, J. J., Perez, M., and Hernandez, F. (2004) Role of tau protein in both physiological and pathological conditions Physiol. Rev. 84, 361-384
48. Kopke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., and Grundke-Iqbal, I. (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease J. Biol. Chem. 268, 24374-24384
49. Galli, R. L., Shukitt-Hale, B., Youdim, K. A., and Joseph, J. A. (2002) Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits Ann. N.Y. Acad. Sci. 959, 128-132
50. Haque, A. M., Hashimoto, M., Katakura, M., Tanabe, Y., Hara, Y., and Shido, O. (2006) Long-term administration of green tea catechins improves spatial cognition learning ability in rats J. Nutr. 136, 1043-1047
51. Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Nagatomi, R., Arai, H., and Tsuji, I. (2006) Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1 Am. J. Clin. Nutr. 83, 355-361
52. Unno, K., Takabayashi, F., Kishido, T., and Oku, N. (2004) Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10) Exp. Gerontol. 39, 1027-1034
53. Wang, Y., Wang, L., Wu, J., and Cai, J. (2006) The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats Br. J. Pharmacol. 148, 147-153
54. Youdim, K. A. and Joseph, J. A. (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects Free Radical Biol. Med. 30, 583-594
55. Sokolov, A. N., Pavlova, M. A., Klosterhalfen, S., and Enck, P. (2013) Chocolate and the brain: Neurobiological impact of cocoa flavanols on cognition and behavior Neurosci. Biobehav. Rev. 37 (10 Pt 2) 2445-2453 10.1016/j.neubiorev.2013.06.013
56. Beecher, G. R. (2003) Overview of dietary flavonoids: nomenclature, occurrence and intake J. Nutr. 133, 3248S-3254S
57. Pietta, P. G. (2000) Flavonoids as antioxidants J. Nat. Prod. 63, 1035-1042
58. Spencer, J. P. (2010) Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain Proc. Nutr. Soc. 69, 244-260
59. Spencer, J. P. (2009) The impact of flavonoids on memory: physiological and molecular considerations Chem. Soc. Rev. 38, 1152-1161
60. Vepsalainen, S., Koivisto, H., Pekkarinen, E., Makinen, P., Dobson, G., McDougall, G. J., Stewart, D., Haapasalo, A., Karjalainen, R. O., Tanila, H., and Hiltunen, M. (2013) Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease J. Nutr. Biochem. 24, 360-370
61. Onozuka, H., Nakajima, A., Matsuzaki, K., Shin, R. W., Ogino, K., Saigusa, D., Tetsu, N., Yokosuka, A., Sashida, Y., Mimaki, Y., Yamakuni, T., and Ohizumi, Y. (2008) Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease J. Pharmacol. Exp. Ther. 326, 739-744
62. Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D. B., and Pasinetti, G. M. (2008) Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease J. Neurosci. 28, 6388-6392
63. Rezai-Zadeh, K., Douglas Shytle, R., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D., Town, T., and Tan, J. (2009) Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production J. Cell. Mol. Med. 13, 574-588
64. Wang, Y. J., Thomas, P., Zhong, J. H., Bi, F. F., Kosaraju, S., Pollard, A., Fenech, M., and Zhou, X. F. (2009) Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse Neurotoxic. Res. 15, 3-14
65. Augustin, S., Rimbach, G., Augustin, K., Schliebs, R., Wolffram, S., and Cermak, R. (2009) Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease Arch. Biochem. Biophys. 481, 177-182
66. Mori, T., Rezai-Zadeh, K., Koyama, N., Arendash, G. W., Yamaguchi, H., Kakuda, N., Horikoshi-Sakuraba, Y., Tan, J., and Town, T. (2012) Tannic acid is a natural beta-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice J. Biol. Chem. 287, 6912-6927
67. Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., and Sugimoto, H. (2008) Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features Biochim. Biophys. Acta 1780, 819-825
68. Shimmyo, Y., Kihara, T., Akaike, A., Niidome, T., and Sugimoto, H. (2008) Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation NeuroReport 19, 1329-1333
69. Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., Hardy, J., Town, T., and Tan, J. (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J. Neurosci. 25, 8807-8814
70. Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Shytle, R. D., and Tan, J. (2008) Green tea epigallocatechin-3- gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice Brain Res. 1214, 177-187
71. Obregon, D. F., Rezai-Zadeh, K., Bai, Y., Sun, N., Hou, H., Ehrhart, J., Zeng, J., Mori, T., Arendash, G. W., Shytle, D., Town, T., and Tan, J. (2006) ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate- induced alpha-secretase cleavage of amyloid precursor protein J. Biol. Chem. 281, 16419-16427
72. Fernandez, J. W., Rezai-Zadeh, K., Obregon, D., and Tan, J. (2010) EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP FEBS Lett. 584, 4259-4267
73. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers Nat. Struct. Mol. Biol. 15, 558-566
74. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity Proc. Natl. Acad. Sci. U.S.A. 107, 7710-7715
75. Hirohata, M., Hasegawa, K., Tsutsumi-Yasuhara, S., Ohhashi, Y., Ookoshi, T., Ono, K., Yamada, M., and Naiki, H. (2007) The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure Biochemistry 46, 1888-1899
76. Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., and Yamada, M. (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease J. Neurochem. 87, 172-181
77. Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S., Iwatsubo, T., Goedert, M., and Hasegawa, M. (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins J. Biol. Chem. 280, 7614-7623
78. Wang, J., Santa-Maria, I., Ho, L., Ksiezak-Reding, H., Ono, K., Teplow, D. B., and Pasinetti, G. M. (2010) Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease J. Alzheimer's Dis. 22, 653-661
79. Pasinetti, G. M., Ksiezak-Reding, H., Santa-Maria, I., Wang, J., and Ho, L. (2010) Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies J. Neurochem. 114, 1557-1568
80. Ho, L., Yemul, S., Wang, J., and Pasinetti, G. M. (2009) Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies J. Alzheimer's Dis. 16, 433-439
81. Ksiezak-Reding, H., Ho, L., Santa-Maria, I., Diaz-Ruiz, C., Wang, J., and Pasinetti, G. M. (2012) Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols Neurobiol. Aging 33, 1427-1439
82. Spencer, J. P. (2007) The interactions of flavonoids within neuronal signalling pathways Genes Nutr. 2, 257-273
83. Spencer, J. P., Rice-Evans, C., and Williams, R. J. (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability J. Biol. Chem. 278, 34783-34793
84. Incani, A., Deiana, M., Corona, G., Vafeiadou, K., Vauzour, D., Dessi, M. A., and Spencer, J. P. (2010) Involvement of ERK, Akt and JNK signalling in H2O2-induced cell injury and protection by hydroxytyrosol and its metabolite homovanillic alcohol Mol. Nutr. Food Res. 54, 788-796
85. Vauzour, D., Vafeiadou, K., and Spencer, J. P. (2007) Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols Biochem. Biophys. Res. Commun. 362, 340-346
86. Ji, X. D., Melman, N., and Jacobson, K. A. (1996) Interactions of flavonoids and other phytochemicals with adenosine receptors J. Med. Chem. 39, 781-788
87. Fernandez, S. P., Mewett, K. N., Hanrahan, J. R., Chebib, M., and Johnston, G. A. (2008) Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice Neuropharmacology 55, 900-907
88. Adachi, N., Tomonaga, S., Tachibana, T., Denbow, D. M., and Furuse, M. (2006) (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain Eur. J. Pharmacol. 531, 171-175
89. Hanrahan, J. R., Chebib, M., and Johnston, G. A. (2011) Flavonoid modulation of GABA(A) receptors Br. J. Pharmacol. 163, 234-245
90. Katavic, P. L., Lamb, K., Navarro, H., and Prisinzano, T. E. (2007) Flavonoids as opioid receptor ligands: identification and preliminary structure-activity relationships J. Nat. Prod. 70, 1278-1282
91. Panneerselvam, M., Tsutsumi, Y. M., Bonds, J. A., Horikawa, Y. T., Saldana, M., Dalton, N. D., Head, B. P., Patel, P. M., Roth, D. M., and Patel, H. H. (2010) Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation A. J. Physiol.: Heart Circ. Physiol. 299, H1604-1609
92. Lee, B. H., Choi, S. H., Shin, T. J., Pyo, M. K., Hwang, S. H., Kim, B. R., Lee, S. M., Lee, J. H., Kim, H. C., Park, H. Y., Rhim, H., and Nah, S. Y. (2010) Quercetin enhances human alpha7 nicotinic acetylcholine receptor-mediated ion current through interactions with Ca(2+) binding sites Mol. Cells 30, 245-253
93. Lee, B. H., Choi, S. H., Shin, T. J., Pyo, M. K., Hwang, S. H., Lee, S. M., Paik, H. D., Kim, H. C., and Nah, S. Y. (2011) Effects of quercetin on alpha9alpha10 nicotinic acetylcholine receptor-mediated ion currents Eur. J. Pharmacol. 650, 79-85
94. Jang, S. W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., and Ye, K. Q. (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proc. Natl. Acad. Sci. U.S.A. 107, 2687-2692
95. Nifli, A. P., Bosson-Kouame, A., Papadopoulou, N., Kogia, C., Kampa, M., Castagnino, C., Stournaras, C., Vercauteren, J., and Castanas, E. (2005) Monomeric and oligomeric flavanols are agonists of membrane androgen receptors Exp. Cell Res. 309, 329-339
96. Han, Y. S., Bastianetto, S., Dumont, Y., and Quirion, R. (2006) Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain J. Pharmacol. Exp. Ther. 318, 238-245
97. Goyarzu, F., Malin, D. H., Lau, F. C., Taglialatela, G., Moon, W. D., Jennings, R., Moy, E., Moy, D., Lippold, S., Shukitt-Hale, B., and Joseph, J. A. (2004) Blueberry supplemented diet: Effects on object recognition memory and nuclear factor-kappa B levels in aged rats Nutr. Neurosci. 7, 75-83
98. Gamet-Payrastre, L., Manenti, S., Gratacap, M. P., Tulliez, J., Chap, H., and Payrastre, B. (1999) Flavonoids and the inhibition of PKC and PI 3-kinase Gen. Pharmacol. 32, 279-286
99. Schroeter, H., Spencer, J. P., Rice-Evans, C., and Williams, R. J. (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3 Biochem. J. 358, 547-557
100. Matter, W. F., Brown, R. F., and Vlahos, C. J. (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs Biochem. Biophys. Res. Commun. 186, 624-631
101. Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C., Remesy, C., Chap, H., and Payrastre, B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition Biochem. Pharmacol. 53, 1649-1657
102. Kong, A. N. T., Yu, R., Chen, C., Mandlekar, S., and Primiano, T. (2000) Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis Arch. Pharm. Res. 23, 1-16
103. Williams, R. J., Spencer, J. P., and Rice-Evans, C. (2004) Flavonoids: antioxidants or signalling molecules? Free. Radical Biol. Med. 36, 838-849
104. Cobb, M. H. and Goldsmith, E. J. (1995) How Map Kinases Are Regulated J. Biol. Chem. 270, 14843-14846
105. Cargnello, M. and Roux, P. P. (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Microbiol. Mol. Biol. Rev. 75, 50-83
106. Kobuchi, H., Roy, S., Sen, C. K., Nguyen, H. G., and Packer, L. (1999) Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway Am. J. Physiol.: Cell Physiol. 277, C403-C411
107. Schroeter, H., Bahia, P., Spencer, J. P., Sheppard, O., Rattray, M., Cadenas, E., Rice-Evans, C., and Williams, R. J. (2007) (-)Epicatechin stimulates ERK-dependent cyclic AMP response element activity and up-regulates GluR2 in cortical neurons J. Neurochem. 101, 1596-1606
108. Vauzour, D., Vafeiadou, K., Rice-Evans, C., Williams, R. J., and Spencer, J. P. (2007) Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons J. Neurochem. 103, 1355-1367
109. Maher, P., Akaishi, T., and Abe, K. (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory Proc. Natl. Acad. Sci. U.S.A. 103, 16568-16573
110. Gopalakrishnan, A., Xu, C. J., Nair, S. S., Chen, C., Hebbar, V., and Kong, A. N. (2006) Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells Arch. Pharm. Res. 29, 633-644
111. Llorens, F., Garcia, L., Itarte, E., and Gomez, N. (2002) Apigenin and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation FEBS Lett. 510, 149-153
112. Schroeter, H., Boyd, C., Spencer, J. P., Williams, R. J., Cadenas, E., and Rice-Evans, C. (2002) MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide Neurobiol. Aging 23, 861-880
113. Impey, S., Smith, D. M., Obrietan, K., Donahue, R., Wade, C., and Storm, D. R. (1998) Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning Nat. Neurosci. 1, 595-601
114. Finkbeiner, S., Tavazoie, S. F., Maloratsky, A., Jacobs, K. M., Harris, K. M., and Greenberg, M. E. (1997) CREB: a major mediator of neuronal neurotrophin responses Neuron 19, 1031-1047
115. Williams, C. M., El Mohsen, M. A., Vauzour, D., Rendeiro, C., Butler, L. T., Ellis, J. A., Whiteman, M., and Spencer, J. P. (2008) Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels Free Radical Biol. Med. 45, 295-305
116. Li, Q., Zhao, H. F., Zhang, Z. F., Liu, Z. G., Pei, X. R., Wang, J. B., and Li, Y. (2009) Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus Neuroscience 163, 741-749
117. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl- 4H-1-benzopyran-4-one (LY294002) J. Biol. Chem. 269, 5241-5248
118. Ferriola, P. C., Cody, V., and Middleton, E., Jr. (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships Biochem. Pharmacol. 38, 1617-1624
119. Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., and Williams, R. L. (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine Mol. Cell 6, 909-919
120. Yin, Y., Edelman, G. M., and Vanderklish, P. W. (2002) The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes Proc. Natl. Acad. Sci. U.S.A. 99, 2368-2373
121. Waltereit, R., Dammermann, B., Wulff, P., Scafidi, J., Staubli, U., Kauselmann, G., Bundman, M., and Kuhl, D. (2001) Arg3.1/Arc mRNA induction by Ca2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation J. Neurosci. 21, 5484-5493
122. Harris, K. M. and Kater, S. B. (1994) Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function Annu. Rev. Neurosci. 17, 341-371
123. van Praag, H., Lucero, M. J., Yeo, G. W., Stecker, K., Heivand, N., Zhao, C., Yip, E., Afanador, M., Schroeter, H., Hammerstone, J., and Gage, F. H. (2007) Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice J. Neurosci. 27, 5869-5878
124. Reznichenko, L., Amit, T., Youdim, M. B., and Mandel, S. (2005) Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth J. Neurochem. 93, 1157-1167
125. Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y. Z., Mandelkow, E. M., Eisenbrand, G., and Meijer, L. (2001) Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276, 251-260
126. Gong, E. J., Park, H. R., Kim, M. E., Piao, S., Lee, E., Jo, D. G., Chung, H. Y., Ha, N. C., Mattson, M. P., and Lee, J. (2011) Morin attenuates tau hyperphosphorylation by inhibiting GSK3beta Neurobiol. Dis. 44, 223-230
127. Qin, L., Zhang, J., and Qin, M. (2013) Protective effect of cyanidin 3-O-glucoside on beta-amyloid peptide-induced cognitive impairment in rats Neurosci. Lett. 534, 285-288